当前位置：
X-MOL 学术
›
JACC Cardiovasc. Imaging
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Molecular Imaging of Apoptosis in Cancer Therapy-Related Cardiac Dysfunction Before LVEF Reduction
JACC: Cardiovascular Imaging ( IF 14.0 ) Pub Date : 2018-08-01 , DOI: 10.1016/j.jcmg.2017.12.012 Takehiro Nakahara , Artiom Petrov , Takashi Tanimoto , Farhan Chaudhry , Navneet Narula , Surya V. Seshan , Jeffrey A. Mattis , Koon Yan Pak , Gagan Sahni , Aarti Bhardwaj , Partho P. Sengupta , Amy Tiersten , H. William Strauss , Jagat Narula
JACC: Cardiovascular Imaging ( IF 14.0 ) Pub Date : 2018-08-01 , DOI: 10.1016/j.jcmg.2017.12.012 Takehiro Nakahara , Artiom Petrov , Takashi Tanimoto , Farhan Chaudhry , Navneet Narula , Surya V. Seshan , Jeffrey A. Mattis , Koon Yan Pak , Gagan Sahni , Aarti Bhardwaj , Partho P. Sengupta , Amy Tiersten , H. William Strauss , Jagat Narula
Detecting chemotherapy-related cardiac dysfunction (CRCD) before a decrease in left ventricular ejection fraction (LVEF) or an enzyme leak may help employ strategies to preserve ventricular function. Although the mechanisms of CRCD are not fully elucidated, myocyte apoptosis has been proposed to
中文翻译：
在左心室射血分数（LVEF）降低或酶泄漏之前检测与化疗相关的心脏功能障碍（CRCD），可能有助于采用保留心室功能的策略。尽管尚未完全阐明CRCD的机制，但已经提出了心肌细胞凋亡可以
更新日期：2018-08-07
中文翻译：
LVEF降低前与癌症治疗相关的心功能不全的细胞凋亡分子成像
在左心室射血分数（LVEF）降低或酶泄漏之前检测与化疗相关的心脏功能障碍（CRCD），可能有助于采用保留心室功能的策略。尽管尚未完全阐明CRCD的机制，但已经提出了心肌细胞凋亡可以
京公网安备 11010802027423号